DMAADrugs Made In America Acquisition Corp.
$10.61
$0.01
(0.09%)
Mkt Cap$257.34M
Vol1,313.00
Fundamentals
Mkt Cap
$257.34M
Volume
-
52W High
$10.61
52W Low
$10.15
PE Ratio
53.53
Avg. Volume
30,606.20
EPS (Annual)
$0.1762
Rev/Employee
$0.00
Earnings
-
Short Interest in Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) Grows By 8,397.5%
Drugs Made In America Acquisition Corp. (NASDAQ:DMAA - Get Free Report) saw a large increase in short interest during the month of April. As of April 15th, there was short interest totaling 1,465,993 shares, an increase of 8,397.5% from the March 31st total of 17,252 shares. Based on an average...
MarketBeat
Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) Sees Large Decrease in Short Interest
Drugs Made In America Acquisition Corp. (NASDAQ:DMAA - Get Free Report) saw a large decrease in short interest in March. As of March 31st, there was short interest totaling 17,252 shares, a decrease of 30.6% from the March 15th total of 24,866 shares. Based on an average daily volume of 43,602...
MarketBeat
JPMorgan Chase & Co. Buys Shares of 99,690 Drugs Made In America Acquisition Corp. $DMAA
JPMorgan Chase & Co. bought a new stake in Drugs Made In America Acquisition Corp. (NASDAQ:DMAA - Free Report) during the 3rd quarter, according to the company in its most recent filing with the...
MarketBeat
Drugs Made In America Acquisition (NASDAQ:DMAA) Shares Down 0% - What's Next?
Drugs Made In America Acquisition (NASDAQ:DMAA) Trading Down 0% - Here's Why...
MarketBeat
Clear Street Group Inc. Acquires New Holdings in Drugs Made In America Acquisition Corp. $DMAA
Clear Street Group Inc. bought a new stake in Drugs Made In America Acquisition Corp. (NASDAQ:DMAA - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the...
MarketBeat
Radcliffe Capital Management L.P. Has $5.42 Million Position in Drugs Made In America Acquisition Corp. $DMAA
Radcliffe Capital Management L.P. increased its stake in shares of Drugs Made In America Acquisition Corp. (NASDAQ:DMAA - Free Report) by 316.7% during the 3rd quarter, according to its most recent...
MarketBeat
Context Capital Management LLC Buys Shares of 250,000 Drugs Made In America Acquisition Corp. $DMAA
Context Capital Management LLC purchased a new position in Drugs Made In America Acquisition Corp. (NASDAQ:DMAA - Free Report) during the third quarter, according to the company in its most recent...
MarketBeat
Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) Short Interest Down 21.7% in February
Drugs Made In America Acquisition Corp. (NASDAQ:DMAA - Get Free Report) saw a large drop in short interest in February. As of February 13th, there was short interest totaling 28,441 shares, a drop of...
MarketBeat
Drugs Made In America Acquisition (NASDAQ:DMAA) Stock Price Up 0.1% - Here's Why
Drugs Made In America Acquisition (NASDAQ:DMAA) Trading 0.1% Higher - Still a Buy...
MarketBeat
Wolverine Asset Management LLC Buys 227,222 Shares of Drugs Made In America Acquisition Corp. $DMAA
Wolverine Asset Management LLC raised its position in shares of Drugs Made In America Acquisition Corp. (NASDAQ:DMAA - Free Report) by 22.2% in the 3rd quarter, according to the company in its most...
MarketBeat
<
1
2
...
>
Advertisement|Remove ads.
Latest DMAA News
ViewShort Interest in Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) Grows By 8,397.5%
MarketBeat
Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) Sees Large Decrease in Short Interest
MarketBeat
JPMorgan Chase & Co. Buys Shares of 99,690 Drugs Made In America Acquisition Corp. $DMAA
MarketBeat
Advertisement|Remove ads.